Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
Vietnam
· Delayed Price · Currency is VND 58,700
0.00 (0.00%)
At close: Feb 21, 2025
HOSE:DBD Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 | 1,256,952 | Upgrade
|
| Revenue Growth (YoY) | 4.59% | 6.24% | -0.24% | 23.99% | -0.38% | Upgrade
|
| Cost of Revenue | 894,975 | 853,250 | 787,170 | 935,939 | 765,813 | Upgrade
|
| Gross Profit | 832,573 | 798,520 | 767,652 | 622,566 | 491,139 | Upgrade
|
| Selling, General & Admin | 526,981 | 501,538 | 494,312 | 405,437 | 309,356 | Upgrade
|
| Operating Expenses | 526,981 | 501,538 | 494,312 | 405,437 | 309,356 | Upgrade
|
| Operating Income | 305,592 | 296,982 | 273,339 | 217,129 | 181,783 | Upgrade
|
| Interest Expense | -4,058 | -6,998 | -1,916 | -1,325 | -6,589 | Upgrade
|
| Interest & Investment Income | 11,605 | 11,635 | 8,733 | 5,137 | 7,056 | Upgrade
|
| Earnings From Equity Investments | 27,063 | 28,704 | 24,786 | 16,083 | 15,238 | Upgrade
|
| Currency Exchange Gain (Loss) | -947.49 | -482.96 | 354.16 | 733.11 | -1,276 | Upgrade
|
| Other Non Operating Income (Expenses) | -14,119 | -9,753 | -6,739 | -5,310 | -3,021 | Upgrade
|
| EBT Excluding Unusual Items | 325,136 | 320,086 | 298,558 | 232,448 | 193,191 | Upgrade
|
| Pretax Income | 325,136 | 320,086 | 298,558 | 232,448 | 193,191 | Upgrade
|
| Income Tax Expense | 49,954 | 51,031 | 55,003 | 43,324 | 35,332 | Upgrade
|
| Net Income | 275,182 | 269,055 | 243,555 | 189,124 | 157,860 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 37,668 | 34,098 | 26,477 | 18,943 | Upgrade
|
| Net Income to Common | 275,182 | 231,387 | 209,457 | 162,646 | 138,916 | Upgrade
|
| Net Income Growth | 2.28% | 10.47% | 28.78% | 19.80% | 10.99% | Upgrade
|
| Shares Outstanding (Basic) | 94 | 94 | 94 | 94 | 94 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 94 | 94 | 94 | 94 | Upgrade
|
| Shares Change (YoY) | -0.00% | - | - | -0.07% | -0.01% | Upgrade
|
| EPS (Basic) | 2941.43 | 2473.29 | 2238.88 | 1738.52 | 1483.83 | Upgrade
|
| EPS (Diluted) | 2941.43 | 2473.29 | 2238.88 | 1738.52 | 1483.83 | Upgrade
|
| EPS Growth | 18.93% | 10.47% | 28.78% | 17.16% | 8.53% | Upgrade
|
| Free Cash Flow | 115,985 | 160,298 | 82,184 | 62,932 | 153,173 | Upgrade
|
| Free Cash Flow Per Share | 1239.77 | 1713.42 | 878.47 | 672.68 | 1636.12 | Upgrade
|
| Dividend Per Share | - | - | 1600.000 | - | 839.161 | Upgrade
|
| Gross Margin | 48.19% | 48.34% | 49.37% | 39.95% | 39.07% | Upgrade
|
| Operating Margin | 17.69% | 17.98% | 17.58% | 13.93% | 14.46% | Upgrade
|
| Profit Margin | 15.93% | 14.01% | 13.47% | 10.44% | 11.05% | Upgrade
|
| Free Cash Flow Margin | 6.71% | 9.70% | 5.29% | 4.04% | 12.19% | Upgrade
|
| EBITDA | 352,272 | 340,193 | 315,005 | 255,818 | 213,592 | Upgrade
|
| EBITDA Margin | 20.39% | 20.60% | 20.26% | 16.41% | 16.99% | Upgrade
|
| D&A For EBITDA | 46,679 | 43,211 | 41,665 | 38,689 | 31,809 | Upgrade
|
| EBIT | 305,592 | 296,982 | 273,339 | 217,129 | 181,783 | Upgrade
|
| EBIT Margin | 17.69% | 17.98% | 17.58% | 13.93% | 14.46% | Upgrade
|
| Effective Tax Rate | 15.36% | 15.94% | 18.42% | 18.64% | 18.29% | Upgrade
|
| Revenue as Reported | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 | 1,256,952 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.